View Older Stories View More Recent Stories
-
Form ABS-EE CITIGROUP COMMERCIAL For: Dec 16
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 10-D CITIGROUP COMMERCIAL For: Dec 17
-
Form 424B2 CITIGROUP INC
-
Form ABS-EE CITIGROUP COMMERCIAL For: Dec 17
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 10-D Citigroup Commercial For: Dec 17
-
Form 10-D CITIGROUP COMMERCIAL For: Dec 17
-
Form 424B2 CITIGROUP INC
-
Form 10-D Citigroup Commercial For: Dec 17
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Millicom (Tigo) share repurchase activity
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Citi Reiterates Buy Rating on Sembcorp Industries (SCI:SP)
-
Citi Reiterates Buy Rating on Keymed Biosciences Inc (2162:HK)
-
Citi Reiterates Buy Rating on Vodafone Idea Ltd. (IDEA:IN)
-
Citi Reiterates Buy Rating on Jiangsu Hengrui Medicine Co. Ltd (600276:CH)
-
Citi Reiterates Neutral Rating on Kawasaki Heavy Industries, Ltd (7012:JP) (KWHIY)
-
Yadea (1585:HK) PT Lowered to HK$15.20 at Citi
-
Citi Reiterates Sell Rating on Sharp Corp. (6753:JP) (SHCAY)
-
Transaction in own shares
-
Form 4 Citi Trends Inc For: Dec 26 Filed by: DUSKIN JONATHAN
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B3 CITIGROUP INC
-
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
-
Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC

